Reply to the letter to the editor ‘Neutropenia in metastatic colorectal cancer receiving trifluridine/tipiracil’ by Colloca et al.
Authors:
- 1 August 2020
- journal article
- letter
- Published by Elsevier in Annals of Oncology
- Vol. 31 (8) , 1085-1087
Abstract
No abstract availableFunding Information
- Taiho Pharmaceutical
This publication has 5 references indexed in Scilit:
- Neutropenia in metastatic colorectal cancer receiving trifluridine/tipiracilAnnals of Oncology, 2020
- Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trialsAnnals of Oncology, 2020
- Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data setESMO Open, 2018
- Exposure-dependent incorporation of trifluridine into DNA of tumors and white blood cells in tumor-bearing mouseCancer Chemotherapy and Pharmacology, 2015
- Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer patients: Assessment of chemotherapy for resolution of unfavourable neutrophiliaJournal of Translational Medicine, 2013